These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 32641587)
1. RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism. Senatus L; López-Díez R; Egaña-Gorroño L; Liu J; Hu J; Daffu G; Li Q; Rahman K; Vengrenyuk Y; Barrett TJ; Dewan MZ; Guo L; Fuller D; Finn AV; Virmani R; Li H; Friedman RA; Fisher EA; Ramasamy R; Schmidt AM JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641587 [TBL] [Abstract][Full Text] [Related]
2. RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes. Daffu G; Shen X; Senatus L; Thiagarajan D; Abedini A; Hurtado Del Pozo C; Rosario R; Song F; Friedman RA; Ramasamy R; Schmidt AM Diabetes; 2015 Dec; 64(12):4046-60. PubMed ID: 26253613 [TBL] [Abstract][Full Text] [Related]
3. 22016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis and Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage. Schmidt AM Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):613-621. PubMed ID: 28183700 [TBL] [Abstract][Full Text] [Related]
4. RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin. Machado-Lima A; López-Díez R; Iborra RT; Pinto RS; Daffu G; Shen X; Nakandakare ER; Machado UF; Corrêa-Giannella MLC; Schmidt AM; Passarelli M Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019603 [TBL] [Abstract][Full Text] [Related]
5. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis. Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587 [TBL] [Abstract][Full Text] [Related]
6. Integral role of receptor for advanced glycation end products (RAGE) in nondiabetic atherosclerosis. Uekita H; Ishibashi T; Shiomi M; Koyama H; Ohtsuka S; Yamamoto H; Yamagishi S; Inoue H; Itabe H; Sugimoto K; Kamioka M; Ohkawara H; Wada I; Yasuchika T Fukushima J Med Sci; 2019; 65(3):109-121. PubMed ID: 31915324 [TBL] [Abstract][Full Text] [Related]
7. López-Díez R; Shen X; Daffu G; Khursheed M; Hu J; Song F; Rosario R; Xu Y; Li Q; Xi X; Zou YS; Li H; Schmidt AM; Yan SF Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1536-1547. PubMed ID: 28642238 [TBL] [Abstract][Full Text] [Related]
8. Atorvastatin Blocks Advanced Glycation End Products Induced Reduction in Macrophage Cholesterol Efflux Mediated With ATP-Binding Cassette Transporters G 1. Xu L; Wang YR; Li PC; Feng B Circ J; 2019 Aug; 83(9):1954-1964. PubMed ID: 31378770 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-mediated chronic low-grade inflammation is regulated by the RAGE-TLR4-PKCβ Zhao L; Li Y; Xu T; Lv Q; Bi X; Liu X; Fu G; Zou Y; Ge J; Chen Z; Zhang W Mol Med; 2022 Jan; 28(1):4. PubMed ID: 35062863 [TBL] [Abstract][Full Text] [Related]
10. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice. Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597 [TBL] [Abstract][Full Text] [Related]
11. RAGE/DIAPH1 and atherosclerosis through an evolving lens: Viewing the cell from the "Inside - Out". Ramasamy R; Shekhtman A; Schmidt AM Atherosclerosis; 2024 Jul; 394():. PubMed ID: 39131441 [TBL] [Abstract][Full Text] [Related]
16. Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice. Bu DX; Rai V; Shen X; Rosario R; Lu Y; D'Agati V; Yan SF; Friedman RA; Nuglozeh E; Schmidt AM Circ Res; 2010 Apr; 106(6):1040-51. PubMed ID: 20133903 [TBL] [Abstract][Full Text] [Related]
18. The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications. Ramasamy R; Shekhtman A; Schmidt AM Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562970 [TBL] [Abstract][Full Text] [Related]
19. Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling. Gao H; Li H; Li W; Shen X; Di B Med Sci Monit; 2017 Dec; 23():6121-6131. PubMed ID: 29278639 [TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes. Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]